Kyoto Prefectural Hospital

Kyoto 602-8566

0 studies enrolling now · 1 studies all time

What they study most

Atopic Dermatitis

Studies at this site

• Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 1 (ECZema TRAlokinumab Trial no. 1) — Completed